Patents by Inventor Pearline Teo

Pearline Teo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11390684
    Abstract: The present invention provides novel IgE antibodies useful for inhibiting or preventing metastatic cancer. Also provided are methods to inhibit tumor metastasis by modulating the activity of at least one non-tumor cell, treating a patient to inhibit or prevent tumor metastases of a primary solid tumor, treating metastatic carcinoma, reducing metastasis of carcinoma cells, and reducing the growth kinetics of a primary solid tumor or a metastasized cell or tumor.
    Type: Grant
    Filed: October 14, 2019
    Date of Patent: July 19, 2022
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Joseph A. Mollick, Pearline Teo, Paul J. Utz
  • Publication number: 20200087413
    Abstract: The present invention provides novel IgE antibodies useful for inhibiting or preventing metastatic cancer. Also provided are methods to inhibit tumor metastasis by modulating the activity of at least one non-tumor cell, treating a patient to inhibit or prevent tumor metastases of a primary solid tumor, treating metastatic carcinoma, reducing metastasis of carcinoma cells, and reducing the growth kinetics of a primary solid tumor or a metastasized cell or tumor.
    Type: Application
    Filed: October 14, 2019
    Publication date: March 19, 2020
    Inventors: Joseph A. Mollick, Pearline Teo, Paul J. Utz
  • Patent number: 10487152
    Abstract: The present invention provides novel IgE antibodies useful for inhibiting or preventing metastatic cancer. Also provided are methods to inhibit tumor metastasis by modulating the activity of at least one non-tumor cell, treating a patient to inhibit or prevent tumor metastases of a primary solid tumor, treating metastatic carcinoma, reducing metastasis of carcinoma cells, and reducing the growth kinetics of a primary solid tumor or a metastasized cell or tumor.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: November 26, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Joseph A Mollick, Pearline Teo, Paul J Utz
  • Patent number: 9587032
    Abstract: The present invention provides novel IgE antibodies useful for inhibiting or preventing metastatic cancer. Also provided are methods to inhibit tumor metastasis by modulating the activity of at least one non-tumor cell, treating a patient to inhibit or prevent tumor metastases of a primary solid tumor, treating metastatic carcinoma, reducing metastasis of carcinoma cells, and reducing the growth kinetics of a primary solid tumor or a metastasized cell or tumor.
    Type: Grant
    Filed: July 11, 2013
    Date of Patent: March 7, 2017
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Joseph A. Mollick, Pearline Teo, Paul J. Utz
  • Publication number: 20150282695
    Abstract: In various embodiments of the present disclosure, there is provided an endoscope including: an elongate shaft body; an optical scope provided within the elongate shaft body, the optical scope comprising an optical aperture provided at the distal end of the optical scope, corresponding to a distal end of the elongate shaft body; an aperture cover provided at the distal end of the elongate shaft body for shielding the optical aperture from debris external to the elongate shaft body; and an actuation system provided at a proximal end of the elongate shaft body; wherein the actuation system drives the aperture cover to rotate.
    Type: Application
    Filed: December 11, 2013
    Publication date: October 8, 2015
    Applicant: Agency for Science, Technology and Research
    Inventors: Hsien Ts'ung Tay, Joon Yin Phoon, Zhao Ying Pearline Teo, Tze Kiat Ng
  • Publication number: 20140370001
    Abstract: The present invention provides novel IgE antibodies useful for inhibiting or preventing metastatic cancer. Also provided are methods to inhibit tumor metastasis by modulating the activity of at least one non-tumor cell, treating a patient to inhibit or prevent tumor metastases of a primary solid tumor, treating metastatic carcinoma, reducing metastasis of carcinoma cells, and reducing the growth kinetics of a primary solid tumor or a metastasized cell or tumor.
    Type: Application
    Filed: July 11, 2013
    Publication date: December 18, 2014
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Joseph A. Mollick, Pearline Teo, Paul J. Utz